Display options
Share it on

Curr Environ Health Rep. 2014 Sep 01;1(3):239-249. doi: 10.1007/s40572-014-0020-1.

Cardiovascular Events Following Smoke-Free Legislations: An Updated Systematic Review and Meta-Analysis.

Current environmental health reports

Miranda R Jones, Joaquin Barnoya, Saverio Stranges, Lia Losonczy, Ana Navas-Acien

Affiliations

  1. Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
  2. Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis, St. Louis MO.
  3. Division of Health Sciences, University of Warwick Medical School, Coventry, UK.
  4. Highland Hospital of Alameda County, Oakland, CA.

PMID: 25328861 PMCID: PMC4198310 DOI: 10.1007/s40572-014-0020-1

Abstract

BACKGROUND: Legislations banning smoking in indoor public places and workplaces are being implemented worldwide to protect the population from secondhand smoke exposure. Several studies have reported reductions in hospitalizations for acute coronary events following the enactment of smoke-free laws.

OBJECTIVE: We set out to conduct a systematic review and meta-analysis of epidemiologic studies examining how legislations that ban smoking in indoor public places impact the risk of acute coronary events.

METHODS: We searched MEDLINE, EMBASE, and relevant bibliographies including previous systematic reviews for studies that evaluated changes in acute coronary events, following implementation of smoke-free legislations. Studies were identified through December 2013. We pooled relative risk (RR) estimates for acute coronary events comparing post- vs. pre-legislation using inverse-variance weighted random-effects models.

RESULTS: Thirty-one studies providing estimates for 47 locations were included. The legislations were implemented between 1991 and 2010. Following the enactment of smoke-free legislations, there was a 12 % reduction in hospitalizations for acute coronary events (pooled RR: 0.88, 95 % CI: 0.85-0.90). Reductions were 14 % in locations that implemented comprehensive legislations compared to an 8 % reduction in locations that only had partial restrictions. In locations with reductions in smoking prevalence post-legislation above the mean (2.1 % reduction) there was a 14 % reduction in events compared to 10 % in locations below the mean. The RRs for acute coronary events associated with enacting smoke-free legislation were 0.87 vs. 0.89 in locations with smoking prevalence pre-legislation above and below the mean (23.1 %), and 0.87 vs. 0.89 in studies from the Americas vs. other regions.

CONCLUSION: The implementation of smoke-free legislations was related to reductions in acute coronary event hospitalizations in most populations evaluated. Benefits are greater in locations with comprehensive legislations and with greater reduction in smoking prevalence post-legislation. These cardiovascular benefits reinforce the urgent need to enact and enforce smoke-free legislations that protect all citizens around the world from exposure to tobacco smoke in public places.

Keywords: Cardiovascular diseases; Legislations; Smoke-free policy; Tobacco smoke pollution

References

  1. Am J Public Health. 2010 Nov;100(11):2206-12 - PubMed
  2. Am J Med. 2011 Jul;124(7):647-54 - PubMed
  3. Ethn Dis. 2003 Summer;13(2 Suppl 2):S88-90 - PubMed
  4. Aust N Z J Public Health. 2009 Dec;33(6):515-20 - PubMed
  5. J Drug Educ. 2007;37(3):217-26 - PubMed
  6. Health Policy. 2013 May;110(2-3):207-13 - PubMed
  7. Soc Sci Med. 2011 May;72(10):1643-51 - PubMed
  8. N Engl J Med. 2008 Jul 31;359(5):482-91 - PubMed
  9. CMAJ. 2010 May 18;182(8):761-7 - PubMed
  10. J Epidemiol Community Health. 2011 Aug;65(8):702-8 - PubMed
  11. PLoS One. 2009;4(1):e4244 - PubMed
  12. BMJ Open. 2013 Nov 25;3(11):e003307 - PubMed
  13. Circulation. 2005 May 24;111(20):2684-98 - PubMed
  14. Eur J Public Health. 2012 Feb;22 Suppl 1:4-9 - PubMed
  15. Chest. 2012 Sep;142(3):673-679 - PubMed
  16. Eur Heart J. 2006 Oct;27(20):2468-72 - PubMed
  17. Int J Chron Obstruct Pulmon Dis. 2008;3(2):285-93 - PubMed
  18. Prev Chronic Dis. 2011 Jul;8(4):A77 - PubMed
  19. Minerva Cardioangiol. 2008 Apr;56(2):197-203 - PubMed
  20. Clin Res Cardiol. 2012 Mar;101(3):227-35 - PubMed
  21. Asian Pac J Cancer Prev. 2013;14(11):6845-50 - PubMed
  22. Kardiol Pol. 2008 Oct;66(10):1107-12 - PubMed
  23. Public Health Rep. 2011 Nov-Dec;126(6):826-33 - PubMed
  24. Am J Public Health. 2011 Mar;101(3):491-6 - PubMed
  25. Public Health. 2012 Apr;126(4):279-85 - PubMed
  26. Tob Control. 2012 Jul;21(4):407-11 - PubMed
  27. Am J Med. 2004 Jul 1;117(1):32-8 - PubMed
  28. J Cardiovasc Nurs. 2006 Nov-Dec;21(6):457-62 - PubMed
  29. BMJ. 2010 Jun 08;340:c2161 - PubMed
  30. Circulation. 2008 Mar 4;117(9):1183-8 - PubMed
  31. Am J Epidemiol. 2012 Oct 1;176(7):642-8 - PubMed
  32. JAMA. 2001 Jul 25;286(4):436-41 - PubMed
  33. BMJ. 2004 Apr 24;328(7446):977-80 - PubMed
  34. Tob Control. 2010 Dec;19(6):469-74 - PubMed
  35. Tumori. 2002 Nov-Dec;88(6):453-6 - PubMed
  36. Can J Public Health. 2008 Jan-Feb;99(1):62-5 - PubMed
  37. Tob Control. 2013 May;22(e1):e16-20 - PubMed
  38. BMJ. 2004 Apr 24;328(7446):980-3 - PubMed
  39. Tob Control. 2012 Jul;21(4):402-6 - PubMed
  40. J Environ Public Health. 2012;2012:589018 - PubMed
  41. PLoS One. 2014 Feb 10;9(2):e88784 - PubMed
  42. BMC Public Health. 2013 May 31;13:529 - PubMed
  43. Circulation. 2006 Oct 3;114(14):1490-6 - PubMed
  44. Circulation. 1987 Oct;76(4):746-52 - PubMed
  45. Am J Public Health. 2007 Nov;97(11):2035-9 - PubMed
  46. J Am Coll Cardiol. 2009 Sep 29;54(14):1249-55 - PubMed
  47. Prev Med. 2007 Aug-Sep;45(2-3):198-201 - PubMed
  48. Circulation. 2009 Oct 6;120(14):1373-9 - PubMed
  49. BMC Public Health. 2011 Mar 03;11:146 - PubMed
  50. PLoS One. 2013;8(3):e56102 - PubMed
  51. Arch Intern Med. 2012 Nov 26;172(21):1635-41 - PubMed
  52. PLoS One. 2013;8(1):e53722 - PubMed
  53. Eur J Prev Cardiol. 2014 Dec;21(12):1575-82 - PubMed
  54. Nicotine Tob Res. 2013 Mar;15(3):745-7 - PubMed
  55. PLoS One. 2013 Apr 24;8(4):e62063 - PubMed
  56. Am J Med. 2014 Jan;127(1):94.e1-6 - PubMed
  57. J Community Health. 2012 Apr;37(2):468-72 - PubMed
  58. Clin Cardiol. 2012 Apr;35(4):205-9 - PubMed
  59. Prev Med. 2007 Jul;45(1):3-8 - PubMed
  60. BMJ. 2007 Sep 15;335(7619):549 - PubMed
  61. Rev Esp Cardiol. 2009 Jul;62(7):812-5 - PubMed
  62. Tob Control. 2006 Jun;15 Suppl 3:iii51-8 - PubMed
  63. Am J Public Health. 2010 Jan;100(1):171-81 - PubMed
  64. Int J Health Serv. 1990;20(3):417-27 - PubMed
  65. Heart. 2010 Oct;96(19):1525-30 - PubMed
  66. PLoS Med. 2013;10(7):e1001480 - PubMed
  67. Swiss Med Wkly. 2011 May 27;141:w13206 - PubMed
  68. Am J Public Health. 2001 Feb;91(2):300-3 - PubMed
  69. Eur J Epidemiol. 2009;24(10):597-602 - PubMed
  70. MMWR Morb Mortal Wkly Rep. 2009 Jan 2;57(51):1373-7 - PubMed
  71. Am J Public Health. 2010 Dec;100(12):2391-2 - PubMed
  72. Health Aff (Millwood). 2012 Dec;31(12):2699-707 - PubMed
  73. Circulation. 2012 Oct 30;126(18):2177-83 - PubMed
  74. Nicotine Tob Res. 2009 Jun;11(6):642-9 - PubMed
  75. PLoS One. 2011 Mar 02;6(3):e17419 - PubMed
  76. Swiss Med Wkly. 2010;140(9-10):133-8 - PubMed
  77. Gesundheitswesen. 2009 Mar;71(3):140-51 - PubMed
  78. Int J Environ Res Public Health. 2010 Dec;7(12):4169-78 - PubMed

Publication Types

Grant support